Skip to content

RNA Therapeutics

Nucleic acid-based therapeutics constitute a core therapeutic modality for Evox’s development programs, and we have sophisticated capabilities for the loading of various nucleic acids (primarily RNAs) into exosomes.

RNA loading is done via either proprietary exogenous or endogenous loading methods, enabling Evox to work across both natural and non-natural oligonucleotides. Solving the non-hepatic delivery challenge of nucleic acid-based drugs – such as siRNAs, anti-sense, mRNA or even gene editing modalities – is a core mission for Evox and tissue-targeted exosomes represent a very promising technology to achieve the delivery of RNA therapeutics.